Beauty Farm Medical and Health Industry Inc. reported that it bought back 47,500 ordinary shares on 12 June 2026 through on-market transactions on the Hong Kong Stock Exchange.

The shares were repurchased at prices ranging between HK$17.62 and HK$18.36, translating into a volume-weighted average cost of approximately HK$18.16 per share and an aggregate outlay of HK$0.86 million. All repurchased shares are being held as treasury shares.

Following the transaction, the number of issued shares outstanding (excluding treasury shares) decreased to 248.96 million, while treasury shares rose to 2.63 million. The total issued share capital remained unchanged at 251.59 million shares. The latest buyback represents 0.0191% of the company’s issued share capital immediately prior to the transaction.

Under the share repurchase mandate approved on 27 June 2025, Beauty Farm is authorised to repurchase up to 23.58 million shares. Including the latest purchase, 2.63 million shares—or 1.12% of the issued share count at the time the mandate was granted—have been repurchased to date.

In line with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 12 July 2026.